The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    Korea falls to Italy in FIFA U-20 World Cup semifinals

  • 3

    Actor Yoo Ah-in suspected of taking 2 more types of drugs

  • 5

    OpenAI explores investment opportunities in Korean startups: Sam Altman

  • 7

    IPO market regains vigor on bullish KOSPI

  • 9

    Gang Dong-won, Park Jeong-min team up for Joseon-era thriller 'War and Revolt'

  • 11

    S. Korea may see rise in NK defectors as Pyongyang mulls reopening borders

  • 13

    Resurging household loans pose challenge for BOK's rate policy

  • 15

    INTERVIEWCIX talks about team chemistry, youth theme

  • 17

    Hyundai Motor partners with Spider-Man animation to envision future mobility

  • 19

    NCT to hold Korea-Japan stadium tour

  • 2

    Rising minimum wage burdens small biz owners: survey

  • 4

    Jihyo to become 2nd TWICE member to make solo debut

  • 6

    'The Childe': blood-soaked crime thriller with chilling chase scenes

  • 8

    China's hallyu restrictions likely to continue unless Seoul-Beijing ties improve

  • 10

    China reaches out to Korean Assembly to counterweigh Yoon's bet on US

  • 12

    Philippines Day celebrated in Gwangju

  • 14

    OpenAI CEO visits Korea as country seeks to encourage AI development

  • 16

    SPC bolsters PR activities in US

  • 18

    NK claims dam collapse in Ukraine occurred with Washington, Kyiv in 'cahoots'

  • 20

    Danish firm insured N. Korean trade fleet for years: report

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
Sun, June 11, 2023 | 03:57
Bio
HLB Science to showcase sepsis treatment at BIO-Europe
Posted : 2022-10-28 14:50
Updated : 2022-10-30 14:30
Baek Byung-yeul
Print PreviewPrint Preview
Font Size UpFont Size Up
Font Size DownFont Size Down
  • facebook
  • twitter
  • kakaolink
  • whatsapp
  • reddit
  • mailto
  • link
                                                                                                 HLB Science researchers conduct research activities. Courtesy of HLB Group
HLB Science researchers conduct research activities. Courtesy of HLB Group

By Baek Byung-yeul

HLB Science, an affiliate of HLB Group, said Friday that it will showcase its sepsis treatment to medical experts and buyers at the BIO-Europe conference, which will be held virtually from Nov. 2 to 4.

BIO-Europe is one of the largest pharmaceutical conferences in the biotechnology industry where around 2,000 companies from over 60 countries participate every year to discuss technology exports and the joint development of new drugs.

During the virtual event, HLB Science plans to introduce its sepsis treatment and super-bacterial antibiotic technologies that are under development to major research institutes and global pharmaceutical companies. Through the showcase, the company also aims to establish partnerships.

Sepsis is a life-threatening condition with a mortality rate of between 30 percent and 50 percent. It is primarily treated with prescription antibiotics.

While attempting to control the secondary immune response initiated by the endotoxins released from gram-negative bacteria during sepsis treatment by antibiotics, the company discovered its sepsis treatment candidate DD-S052P.

The company said its candidate has dual functions as it can directly kill the bacteria and binds the endotoxins released as a byproduct of the killing process.

With low toxicity, DD-S052P is a promising candidate to treat endotoxin-releasing gram-negative bacterial infections and multidrug-resistant bacterial infections, which both are currently regarded as serious public health issues.

In July, the company earned an approval for the initial new drug application from the French National Agency for Medicines and Health Products Safety (ANSM) and is currently preparing clinical trials on 72 healthy people in France.

"By participating in BIO-Europe, we expect we can work closely with global partners with high capabilities in this sector to expand clinical trials in more countries," said Yoon Jong-sun, the CEO of the company.

Emailbaekby@koreatimes.co.kr Article ListMore articles by this reporter
 
wooribank
Top 10 Stories
1Rising minimum wage burdens small biz owners: survey Rising minimum wage burdens small biz owners: survey
2OpenAI explores investment opportunities in Korean startups: Sam Altman OpenAI explores investment opportunities in Korean startups: Sam Altman
3IPO market regains vigor on bullish KOSPI IPO market regains vigor on bullish KOSPI
4China reaches out to Korean Assembly to counterweigh Yoon's bet on US China reaches out to Korean Assembly to counterweigh Yoon's bet on US
5S. Korea may see rise in NK defectors as Pyongyang mulls reopening borders S. Korea may see rise in NK defectors as Pyongyang mulls reopening borders
6Resurging household loans pose challenge for BOK's rate policy Resurging household loans pose challenge for BOK's rate policy
7SPC bolsters PR activities in US SPC bolsters PR activities in US
8Hyundai Motor partners with Spider-Man animation to envision future mobility Hyundai Motor partners with Spider-Man animation to envision future mobility
9Japanese business leaders pledge to support Busan's Expo bid Japanese business leaders pledge to support Busan's Expo bid
10More foreign language tours will be offered for Cheong Wa Dae More foreign language tours will be offered for Cheong Wa Dae
Top 5 Entertainment News
1China's hallyu restrictions likely to continue unless Seoul-Beijing ties improve China's hallyu restrictions likely to continue unless Seoul-Beijing ties improve
2Gang Dong-won, Park Jeong-min team up for Joseon-era thriller 'War and Revolt' Gang Dong-won, Park Jeong-min team up for Joseon-era thriller 'War and Revolt'
3[INTERVIEW] CIX talks about team chemistry, youth theme INTERVIEWCIX talks about team chemistry, youth theme
4Netflix's new original 'Bloodhounds' to deliver cathartic actionNetflix's new original 'Bloodhounds' to deliver cathartic action
5'Leaving Las Vegas' director Mike Figgis puts Korea in spotlight in new film 'Leaving Las Vegas' director Mike Figgis puts Korea in spotlight in new film
DARKROOM
  • Turkey-Syria earthquake

    Turkey-Syria earthquake

  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group